Sequential Use of Teriparatide and Raloxifene HCl in the Treatment of Postmenopausal Women With Osteoporosis
Status:
Completed
Trial end date:
2005-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the increase in spine bone mineral density
that has been generally observed in previous clinical studies involving the study drug can be
maintained or even increased if followed with raloxifene HCl. All qualifying study
participants will receive the study drug followed by treatment with raloxifene HCl or
placebo. All study participants will receive raloxifene HCl in the third phase of the study.